## Abstract The Bayes factor is a summary measure that provides an alternative to the __P__βvalue for the ranking of associations, or the flagging of associations as βsignificantβ. We describe an approximate Bayes factor that is straightforward to use and is appropriate when sample sizes are large.
P-value based analysis for shared controls design in genome-wide association studies
β Scribed by Dmitri V. Zaykin; Damian O. Kozbur
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 212 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
An appealing genomeβwide association study design compares one large control group against several disease samples. A pioneering study by the Wellcome Trust Case Control Consortium that employed such a design has identified multiple susceptibility regions, many of which have been independently replicated. While reusing a control sample provides effective utilization of data, it also creates correlation between association statistics across diseases. An observation of a large association statistic for one of the diseases may greatly increase chances of observing a spuriously large association for a different disease. Accounting for the correlation is also particularly important when screening for SNPs that might be involved in a set of diseases with overlapping etiology. We describe methods that correct association statistics for dependency due to shared controls, and we describe ways to obtain a measure of overall evidence and to combine association signals across multiple diseases. The methods we describe require no access to individual subject data, instead, they efficiently utilize information contained in Pβvalues for association reported for individual diseases. Pβvalue based combined tests for association are flexible and essentially as powerful as the approach based on aggregating the individual subject data. Genet. Epidemiol. 34:725β738, 2010.Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Many complex diseases are influenced by genetic variations in multiple genes, each with only a small marginal effect on disease susceptibility. Pathway analysis, which identifies biological pathways associated with disease outcome, has become increasingly popular for genomeβwide associa
In genome-wide association studies (GWAS), it is a common practice to impute the genotypes of untyped single nucleotide polymorphism (SNP) by exploiting the linkage disequilibrium structure among SNPs. The use of imputed genotypes improves genome coverage and makes it possible to perform meta-analys
In this article, we develop a powerful test for identifying single nucleotide polymorphism (SNP)-sets that are predictive of survival with data from genome-wide association studies. We first group typed SNPs into SNP-sets based on genomic features and then apply a score test to assess the overall ef
## Abstract Genomeβwide scans of nucleotide variation in human subjects are providing an increasing number of replicated associations with complex disease traits. Most of the variants detected have small effects and, collectively, they account for a small fraction of the total genetic variance. Ver
## Abstract The large number of markers considered in a genomeβwide association study (GWAS) has resulted in a simplification of analyses conducted. Most studies are analyzed one marker at a time using simple tests like the trend test. Methods that account for the special features of genetic associ